Cargando…

Impact of N-acetyl-l-cysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study

Patients receiving N-acetyl-l-cysteine (NAC) during hospitalisation for #SARSCoV2 pneumonia and discharged alive present a significantly shorter length of hospital stay compared to those who did not receive NAC https://bit.ly/3l1QsVo

Detalles Bibliográficos
Autores principales:	Faverio, Paola, Rebora, Paola, Rossi, Emanuela, Del Giudice, Savino, Montanelli, Filippo, Garzillo, Laura, Busnelli, Sara, Luppi, Fabrizio, Valsecchi, Maria Grazia, Pesci, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646003/ https://www.ncbi.nlm.nih.gov/pubmed/35136824 http://dx.doi.org/10.1183/23120541.00542-2021

Ejemplares similares

Molecular Biomarkers in Idiopathic Pulmonary Fibrosis: State of the Art and Future Directions
por: Stainer, Anna, et al.
Publicado: (2021)

Rehospitalization for pneumonia after first pneumonia admission: Incidence and predictors in a population-based cohort study
por: Faverio, Paola, et al.
Publicado: (2020)

Influenza A/H1N1 Severe Pneumonia: Novel Morphocytological Findings in Bronchoalveolar Lavage
por: Faverio, Paola, et al.
Publicado: (2014)

Interstitial Pneumonia with Autoimmune Features: Why Rheumatologist-Pulmonologist Collaboration Is Essential
por: Sebastiani, Marco, et al.
Publicado: (2020)

Interstitial pneumonia associated with autoimmune diseases: a possible mimicker of SARS-CoV-2 pneumonia
por: Pozzi, Maria Rosa, et al.
Publicado: (2021)

Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis
por: Dei, Giulia, et al.
Publicado: (2020)

Concurrent features of sarcoidosis and hypersensitivity pneumonitis in two patients exposed to fungal antigens
por: Marruchella, Almerico, et al.
Publicado: (2023)

Idiopathic interstitial pneumonia in a patient with von Hippel–Lindau syndrome: a first case
por: Morlacchi, Letizia Corinna, et al.
Publicado: (2023)

Sampling strategies to evaluate the prognostic value of a new biomarker on a time-to-event end-point
por: Graziano, Francesca, et al.
Publicado: (2021)

Correction: Sampling strategies to evaluate the prognostic value of a new biomarker on a time-to-event end-point
por: Graziano, Francesca, et al.
Publicado: (2022)

RA-ILD: does more detailed radiological classification add something to our knowledge of this condition?
por: Faverio, Paola, et al.
Publicado: (2020)

Feasibility of CPAP application and variables related to worsening of respiratory failure in pregnant women with SARS-CoV-2 pneumonia: Experience of a tertiary care centre
por: Faverio, Paola, et al.
Publicado: (2021)

Crude incidence in two-phase designs in the presence of competing risks
por: Rebora, Paola, et al.
Publicado: (2016)

Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: do we need a personalized approach?
por: Paolini, Valentina, et al.
Publicado: (2018)

Idiopathic pulmonary fibrosis beyond the lung: understanding disease mechanisms to improve diagnosis and management
por: Luppi, Fabrizio, et al.
Publicado: (2021)

Long-term macrolides in diffuse interstitial lung diseases
por: Faverio, Paola, et al.
Publicado: (2017)

Frailty index predicts poor outcome in COVID-19 patients
por: Bellelli, Giuseppe, et al.
Publicado: (2020)

One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study
por: Faverio, Paola, et al.
Publicado: (2022)

Frailty and long-COVID: is COVID-19 responsible for a transition in frailty status among older adults who survived hospitalization for COVID-19?
por: Ferrara, Maria Cristina, et al.
Publicado: (2022)

Effectiveness and economic impact of Dupilumab in asthma: a population-based cohort study
por: Faverio, Paola, et al.
Publicado: (2023)

Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy
por: Faverio, Paola, et al.
Publicado: (2018)

N-Acetyl-Cysteine: Modulating the Cysteine Redox Proteome in Neurodegenerative Diseases
por: Martinez-Banaclocha, Marcos
Publicado: (2022)

Amelioration of Acute Sequelae of Blast Induced Mild Traumatic Brain Injury by N-Acetyl Cysteine: A Double-Blind, Placebo Controlled Study
por: Hoffer, Michael E., et al.
Publicado: (2013)

Sleep-Disordered Breathing and Chronic Respiratory Infections: A Narrative Review in Adult and Pediatric Population
por: Faverio, Paola, et al.
Publicado: (2023)

Atrial Fibrillation and Clinical Outcomes in a Cohort of Hospitalized Patients with Sars-Cov-2 Infection and Chronic Kidney Disease
por: Genovesi, Simonetta, et al.
Publicado: (2021)

N-Acetyl Cysteine as an Adjunct in the Treatment of Tuberculosis
por: Ejigu, Dawit A., et al.
Publicado: (2020)

Prevention of ventilator-associated pneumonia in the intensive care unit: A review of the clinically relevant recent advancements
por: Keyt, Holly, et al.
Publicado: (2014)

Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD
por: Ronco, Raffaella, et al.
Publicado: (2023)

Lifelong Lung Sequelae of Prematurity
por: Di Filippo, Paola, et al.
Publicado: (2022)

N-acetyl-L-cysteine reduces Leishmania amazonensis-induced inflammation in BALB/c mice
por: Crupi, Rosalia, et al.
Publicado: (2020)

N-acetyl-L-cysteine and cysteine increase intracellular calcium concentration in human neutrophils
por: Hasan, Md. Ashraful, et al.
Publicado: (2016)

Mechanical Ventilation in COVID-19 Patients: Insights into the Role of Age and Frailty from a Multicentre Observational Study
por: Ecarnot, Fiona, et al.
Publicado: (2022)

Efficacy of N-Acetyl Cysteine in Traumatic Brain Injury
por: Eakin, Katharine, et al.
Publicado: (2014)

A Review on Various Uses of N-Acetyl Cysteine
por: Mokhtari, Vida, et al.
Publicado: (2017)

N-acetyl Cysteine Use in the Treatment of Shock Liver
por: Parvataneni, Swetha, et al.
Publicado: (2020)

S-Nitroso-N-acetyl-L-cysteine ethyl ester (SNACET) and N-acetyl-L-cysteine ethyl ester (NACET)–Cysteine-based drug candidates with unique pharmacological profiles for oral use as NO, H(2)S and GSH suppliers and as antioxidants: Results and overview
por: Tsikas, Dimitrios, et al.
Publicado: (2018)

Synthesis of thia-Michael-Type Adducts between Naphthoquinones and N-Acetyl-L-Cysteine and Their Biological Activity
por: Micheletti, Gabriele, et al.
Publicado: (2022)

Nontuberculous mycobacterial pulmonary disease: an integrated approach beyond antibiotics
por: Faverio, Paola, et al.
Publicado: (2021)

Reply to the editor
por: Faverio, Paola
Publicado: (2014)

Correction: Efficacy of N-Acetyl Cysteine in Traumatic Brain Injury
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_h1ceo8emtvcqbn2sbpqjkfsgue